Impact of pregravid obesity on maternal and fetal immunity: Fertile grounds for reprogramming

Suhas Sureshchandra, Nicole Marshall, Ilhem Messaoudi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Maternal pregravid obesity results in several adverse health outcomes during pregnancy, including increased risk of gestational diabetes, preeclampsia, placental abruption, and complications at delivery. Additionally, pregravid obesity and in utero exposure to high fat diet have been shown to have detrimental effects on fetal programming, predisposing the offspring to adverse cardiometabolic, endocrine, and neurodevelopmental outcomes. More recently, a deeper appreciation for the modulation of offspring immunity and infectious disease-related outcomes by maternal pregravid obesity has emerged. This review will describe currently available animal models for studying the impact of maternal pregravid obesity on fetal immunity and review the data from clinical and animal model studies. We also examine the burden of pregravid obesity on the maternal–fetal interface and the link between placental and systemic inflammation. Finally, we discuss future studies needed to identify key mechanistic underpinnings that link maternal inflammatory changes and fetal cellular reprogramming events.

Original languageEnglish (US)
JournalJournal of Leukocyte Biology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Immunity
Obesity
Mothers
Animal Models
Abruptio Placentae
Gestational Diabetes
High Fat Diet
Pregnancy Outcome
Fetal Development
Pre-Eclampsia
Communicable Diseases
Inflammation
Health

Keywords

  • obesity
  • placenta
  • pregnancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Cell Biology

Cite this

Impact of pregravid obesity on maternal and fetal immunity : Fertile grounds for reprogramming. / Sureshchandra, Suhas; Marshall, Nicole; Messaoudi, Ilhem.

In: Journal of Leukocyte Biology, 01.01.2019.

Research output: Contribution to journalReview article

@article{ceb4db9319844ea5a6fc636df769d2d7,
title = "Impact of pregravid obesity on maternal and fetal immunity: Fertile grounds for reprogramming",
abstract = "Maternal pregravid obesity results in several adverse health outcomes during pregnancy, including increased risk of gestational diabetes, preeclampsia, placental abruption, and complications at delivery. Additionally, pregravid obesity and in utero exposure to high fat diet have been shown to have detrimental effects on fetal programming, predisposing the offspring to adverse cardiometabolic, endocrine, and neurodevelopmental outcomes. More recently, a deeper appreciation for the modulation of offspring immunity and infectious disease-related outcomes by maternal pregravid obesity has emerged. This review will describe currently available animal models for studying the impact of maternal pregravid obesity on fetal immunity and review the data from clinical and animal model studies. We also examine the burden of pregravid obesity on the maternal–fetal interface and the link between placental and systemic inflammation. Finally, we discuss future studies needed to identify key mechanistic underpinnings that link maternal inflammatory changes and fetal cellular reprogramming events.",
keywords = "obesity, placenta, pregnancy",
author = "Suhas Sureshchandra and Nicole Marshall and Ilhem Messaoudi",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/JLB.3RI0619-181R",
language = "English (US)",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",

}

TY - JOUR

T1 - Impact of pregravid obesity on maternal and fetal immunity

T2 - Fertile grounds for reprogramming

AU - Sureshchandra, Suhas

AU - Marshall, Nicole

AU - Messaoudi, Ilhem

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Maternal pregravid obesity results in several adverse health outcomes during pregnancy, including increased risk of gestational diabetes, preeclampsia, placental abruption, and complications at delivery. Additionally, pregravid obesity and in utero exposure to high fat diet have been shown to have detrimental effects on fetal programming, predisposing the offspring to adverse cardiometabolic, endocrine, and neurodevelopmental outcomes. More recently, a deeper appreciation for the modulation of offspring immunity and infectious disease-related outcomes by maternal pregravid obesity has emerged. This review will describe currently available animal models for studying the impact of maternal pregravid obesity on fetal immunity and review the data from clinical and animal model studies. We also examine the burden of pregravid obesity on the maternal–fetal interface and the link between placental and systemic inflammation. Finally, we discuss future studies needed to identify key mechanistic underpinnings that link maternal inflammatory changes and fetal cellular reprogramming events.

AB - Maternal pregravid obesity results in several adverse health outcomes during pregnancy, including increased risk of gestational diabetes, preeclampsia, placental abruption, and complications at delivery. Additionally, pregravid obesity and in utero exposure to high fat diet have been shown to have detrimental effects on fetal programming, predisposing the offspring to adverse cardiometabolic, endocrine, and neurodevelopmental outcomes. More recently, a deeper appreciation for the modulation of offspring immunity and infectious disease-related outcomes by maternal pregravid obesity has emerged. This review will describe currently available animal models for studying the impact of maternal pregravid obesity on fetal immunity and review the data from clinical and animal model studies. We also examine the burden of pregravid obesity on the maternal–fetal interface and the link between placental and systemic inflammation. Finally, we discuss future studies needed to identify key mechanistic underpinnings that link maternal inflammatory changes and fetal cellular reprogramming events.

KW - obesity

KW - placenta

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85071772831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071772831&partnerID=8YFLogxK

U2 - 10.1002/JLB.3RI0619-181R

DO - 10.1002/JLB.3RI0619-181R

M3 - Review article

C2 - 31483523

AN - SCOPUS:85071772831

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

ER -